Company news
Puretech Health Plc (LSE:PRTC) news
Puretech Health Plc news releases on 6ix. Latest, Jan 5, 2022: Gelesis Adds to BOD & Declared Effective by SEC
Press releases — page 5
Gelesis Adds to BOD & Declared Effective by SEC
January 5, 2022
PRTC Provides Recap Ahead of Catalyst-Rich 2022
December 16, 2021
PRTC Presents Data at ACNP Conference For LYT-300
December 8, 2021
PRTC's Lymphatic Platform Candidate Human Study
December 7, 2021
PRTC: Gelesis' Plenity Now Broadly Available in US
December 1, 2021
PRTC's Gelesis Receives $30M Plenity Order from Ro
November 18, 2021
PRTC Publishes Previous LYT-100 MAD Study Results
November 16, 2021
PRTC Presents Immunooncology Ph 1/2 Trial at SITC
November 12, 2021
PRTC Receives $100M from Founded Entity Shares
November 10, 2021
KRTX and Zai Lab to Develop KarXT in Greater China
November 9, 2021
New Research in Journal Nature on Gelesis Tech
November 1, 2021
Holdings in Company - TR-1 Correction Announcement
October 22, 2021
Price Monitoring Extension
October 20, 2021
PRTC's Vedanta Appoints Chief Legal Officer
October 14, 2021
Additional Listing
October 12, 2021
Vedanta Positive Phase 2 Data in C. Diff Infection
October 5, 2021
Akili/Shionogi Report Positive Ph2 Data in Japan
September 29, 2021
New PureTech Research Published In Nature Journal
September 20, 2021
PRTC to Present at Oppenheimer Healthcare Summit
September 14, 2021
PRTC's Vor Granted FDA Fast Track Designation
September 10, 2021
PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS
August 23, 2021
Akili Deal Furthers Digital Medicine Leadership
August 17, 2021
PRTC Appoints Industry Veteran & Physician as CMO
August 13, 2021
PRTC Receives $6.5M; Imbrium to Develop LYT-503
August 11, 2021
PRTC's Akili Releases New Features for EndeavorRx
July 22, 2021
PureTech's Vedanta Raises $68M Series D Financing
July 21, 2021
PRTC's Gelesis to Become Public Via Capstar SPAC
July 19, 2021
PRTC's Vor Announces Collaboration with Janssen
July 9, 2021
PRTC's Sonde Announces Collaboration With Qualcomm
July 8, 2021
PRTC BeiGene LYT-200 Clinical Trial Agreement
July 7, 2021
PRTC's Vedanta Announces New Data from IBD Study
June 30, 2021
Karuna Announces KarXT Results in Healthy Elderly
June 23, 2021
PureTech Acquires Alivio and Oral IL-22 Candidate
June 16, 2021
PureTech's Gelesis Presents Plenity Data at AACE
May 27, 2021
PureTech's Akili Secures $160M in Financing
May 26, 2021
PRTC Presents at Jefferies Healthcare Conference
May 25, 2021
PureTech Forms IPF Clinical Advisory Board
May 12, 2021
New PureTech Research Published in Nature Journal
April 28, 2021
Gelesis Appoints Procter & Gamble Veteran to BOD
April 26, 2021
PRTC Presents Data for LYT-210 IO Program at AACR
April 12, 2021
PureTech to Present at Two Investor Conferences
April 7, 2021
Akili Data Published in Nature Digital Medicine
March 26, 2021
PRTC Presents at Barclays Healthcare Conference
March 3, 2021
Karuna Prices Approximately $250M Public Offering
March 2, 2021
PRTC Publishes Lymphatic Targeting Study for Glyph
February 25, 2021
PRTC Presents at SVB Leerink Healthcare Conference
February 18, 2021
Vor Closes Over $200M Initial Public Offering
February 10, 2021
Vedanta Adds Biotech Finance and IR Expert as CFO
February 8, 2021
PureTech Founded Entity Vor Lists on Nasdaq
February 5, 2021
PureTech Appoints Bharatt Chowrira to BOD
January 29, 2021